Cargando…
Folate receptor-targeted liposomes enhanced the antitumor potency of imatinib through the combination of active targeting and molecular targeting
PURPOSE: Imatinib inhibits platelet-derived growth factor receptor (PDGFR), and evidence shows that PDGFR participates in the development and progression of cervical cancer. Although imatinib has exhibited preclinical activity against cervical cancer, only minimal clinical therapeutic efficacy was o...
Autores principales: | Ye, Peng, Zhang, Wendian, Yang, Tan, Lu, Yao, Lu, Miao, Gai, Yongkang, Ma, Xiang, Xiang, Guangya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4019625/ https://www.ncbi.nlm.nih.gov/pubmed/24855354 http://dx.doi.org/10.2147/IJN.S60178 |
Ejemplares similares
-
Targeted delivery of chemically modified anti-miR-221 to hepatocellular carcinoma with negatively charged liposomes
por: Zhang, Wendian, et al.
Publicado: (2015) -
Co-delivery of Doxorubicin and Bmi1 siRNA by Folate Receptor Targeted Liposomes Exhibits Enhanced Anti-Tumor Effects in vitro and in vivo
por: Yang, Tan, et al.
Publicado: (2014) -
A novel hydrolysis-resistant lipophilic folate derivative enables stable delivery of targeted liposomes in vivo
por: Huang, Yifei, et al.
Publicado: (2014) -
Folate receptor-targeted fluorescent paramagnetic bimodal liposomes for tumor imaging
por: Ding, Nan, et al.
Publicado: (2011) -
Antitumor activity of a folate receptor-targeted immunoglobulin G-doxorubicin conjugate
por: Yang, Tan, et al.
Publicado: (2017)